Fetal and Neonatal Alloimmune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Fetal and Neonatal Alloimmune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) [Phase 3]
This document provides an update on a Phase 3 study evaluating Nipocalimab to reduce fetal and neonatal alloimmune thrombocytopenia (FNAIT).…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) [Phase 3]
A Phase 3 clinical trial comparing Nipocalimab to intravenous immunoglobulin (IVIG) in pregnancies at risk for fetal and neonatal alloimmune…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization [Phase 2]
Phase 2 study evaluating the pharmacokinetics and safety of RLYB212 in pregnant women at high risk for HPA-1a alloimmunization (fetal and ne…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
The clinical trial investigating the occurrence of HPA-1a alloimmunization in women at high risk for fetal and neonatal alloimmune thrombocy…